On the other hand, Caldas et al. [42] suggested that increased production of IFN-γ associated with clinical cure of visceral leishmaniasis occurs late and is likely to be related to systemic reduction of IL-10, but not to antigen-specific reduction. The gene discussed is IL10; the disease is visceral leishmaniasis.